Some patients use weight loss treatments for a defined period, while others may require longer-term therapy based on medical evaluation and response
Where AOD 9604 directly attacks fat cells through adrenergic receptors, tirzepatide works upstream by modifying appetite signaling, insulin response, and gastric emptying
Tirzepatide + NAD+ (Coming Soon) Imagine pairing tirzepatides proven metabolic effects with NAD+, a crucial molecule for cellular energy
With tirzepatide, results tend to be even greater, with patients losing up to 20% or more of their body weight
There is no direct conversion chart between semaglutide and tirzepatide, as both medications have different doses and titration schedules
However, prolonged discontinuation may compromise glycaemic control and cause rebound appetite